Walder Wyss AG acted as Swiss counsel to Bavarian Nordic. Bavarian Nordic, a vaccine company, has entered into a definitive agreement to acquire Emergent BioSolutions’ travel...
Bavarian Nordic’s $380 Million Acquisition of Emergent BioSolutions’ Travel Vaccines Portfolio
Bavarian Nordic’s DKK 1,642 Million Shares Private Placement
Kromann Reumert assisted Bavarian Nordic with the transaction. Bavarian Nordic A/S announced the launch of a private placing of new ordinary shares, at a price to...
Bavarian Nordic’s DKK 800 Million State Aid Agreement For a Danish COVID-19 Vaccine Development
Kromann Reumert has assisted Bavarian Nordic on the deal. The Danish vaccines company Bavarian Nordic A/S has entered a funding agreement with the Danish Ministry of Health...
Bavarian Nordic’s DKK 1,148.45 Million Shares Private Placement
Kromann Reumert has assisted Bavarian Nordic on the deal. Bavarian Nordic A/S announced the launch of a private placement of new ordinary shares, at a price...